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Abstract: 
The cell culture has become over the years an important discipline for the 
thorough knowledge of cells behaviour and migration, as also cell-cell interaction. A 
few years ago it was only possible to create culture systems in vitro systems, however, 
with the advance of new technologies it has become possible to create culture systems 
in vivo closer to reality. 
The microfabrication processes such as photolithography were used in this work 
for the design of a microdevice which is aimed to study the migration of cells into 
nanofibers. 
Beyond the cell studies, microdevices were also used for rheological studies. 
The behaviour of blood cells is very important, regarding the transport of oxygen in our 
body as well as nutrients. The knowledge about the factors that influence changes in 
mechanical properties of erythrocytes is of great importance because it is their 
deformability that allows them to carry oxygen and pass through smaller arteries and 
veins. Therefore, another microdevice was used for the purpose of observing the 
deformation of the erythrocytes after contact with human tumour cell lines (NCI-H460- 
non-small cell lung cancer and HCT-15 - colon carcinoma) up to two consecutive days. 
With the flow rate of 500 nl/min, the flowing erythrocytes through the microchannel 
were captured by a high speed camera and their deformability was examined. The 
erythrocytes that contacted tumour cells show less deformability than ―healthy‖ 
erythrocytes. 
It was found that the tests were insufficient to conclude clearly the effect of the 
tumour cells in the deformation of erythrocytes. We have found evidence that 
erythrocytes also influence the growth of tumour cells, however, further testing would 
be needed to clarify this observation. 
 
Keywords: Biomedical devices, nanofibers, cell culture, erythrocytes, cancer 
cells, deformability 
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Resumo: 
A cultura de células tornou-se ao longo dos anos uma importante disciplina para 
o conhecimento profundo do seu comportamento, migração e interação entre células. 
Com o avanço de novas tecnologias tornou-se possível criar sistemas de cultura in vivo 
mais próximos da realidade, quando anteriormente apenas existiam sistemas in vitro.  
Neste trabalho, foram aplicados processos de microfabricação, nomeadamente a 
fotolitografia, para a conceção de um microdispositivo que teve como objetivo principal 
o estudo da migração de células em nanofibras. 
Para além de estudos celulares, os microdispositivos também foram usados em 
estudos reológicos. O comportamento do sangue é muito importante, pois é ele que 
transporta o oxigénio no nosso organismo assim como nutrientes. Perceber o que 
influencia a alteração das características mecânicas dos eritrócitos é de grande 
importância pois é a sua deformabilidade que lhes permite transportar o oxigénio e 
passar nas artérias e veias mais pequenas. Assim, utilizou-se um outro microdispositivo, 
com o propósito de observar a deformação dos eritrócitos após contacto com linhas 
celulares tumorais humanas (NCI-H460 – cancro do pulmão e HCT-15 – carcinoma do 
cólon) até um máximo de dois dias consecutivos. Os eritrócitos fluíram pelo microcanal 
com uma taxa de fluxo de 500 nl/min e foram capturados por uma câmara de alta 
velocidade para ver a sua capacidade de deformação. Os eritrócitos que estiveram em 
contacto com as células tumorais revelam menos deformação que os eritrócitos 
―saudáveis‖. 
Verificou-se que os ensaios realizados foram insuficientes para concluir com 
clareza o efeito das células tumorais na deformação dos eritrócitos. Encontraram-se 
também indícios de os eritrócitos influenciarem o crescimento das células tumorais, no 
entanto, mais ensaios também seriam necessários para clarificar essas observações. 
 
Palavras-chave: Dispositivos biomédicos, nanofibras, cultura de células, 
eritrócitos, células cancerígenas, deformação 
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1. Objectives and motivation 
Over the years, cell culture has become an important discipline for the thorough 
knowledge of their behaviour, migration and cell-cell interaction. With the advance of 
new technologies, it has been possible to create live culture systems in approximate 
reality. The cell cultures are made using means which feed the cells and flasks suitable 
for this purpose. However, the cultures are static and often not accurately reflect the 
conditions of the cells in a living organism. 
Thus, microdevices obtained by microfabrication processes such as 
photolithography, emerged as good examples of new methods for studying cells both 
individually and together. There are many types of microdevices for toxicological 
studies, migration and cell individualization. Having in mind the purpose of performing 
studies in similar conditions to human body, new scaffolds for culture cells and tissues 
have been developed, namely nanofibers.  Nanofibers are polymeric matrices that have 
as main objective to serve as support cells. So their material should have the following 
features: biocompatibility and biodegradability. 
Besides cell studies, microdevices are also used for rheological studies. The 
behaviour of blood cells is very important, regarding its function carrying oxygen in our 
body as well as nutrients. The knowledge about the factors that influence the change in 
mechanical properties of erythrocytes is of great importance because it is their 
deformability that allows them to carry oxygen and pass smaller veins. 
Herein, a device was created in order to study the migration of cells in the 
nanofibers. Several tests were made to assess its viability and various techniques were 
used to achieve the objective.  
Another microdevice was used with the purpose of study the deformation of the 
erythrocytes, after contact with tumour cell lines (NCI-H460 - non-small cell lung 
cancer and HCT-15 - colon carcinoma) up to two consecutive days. With the flow rate 
of 500 nl/min, the flowing erythrocytes through the microchannel were captured by a 
high speed camera and their deformability was examined. The images were processed 
and the data taken with Image Analyzer (ImageJ, developed by the National Institute of 
Health, USA). 
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2. Cell Culture 
Since the moment in which it was possible to differentiate and culture animal 
cells, the cell research has been growing and has great importance. This advances 
enabled the study of diseases such as cancer and of advances to treat them. 
Animal cell culture began in 1907 by Ross Harrison, but only between 1940‘s 
and 1950‘s became an important tool for scientists due some developments that are now 
part of procedures (Ryan, 2008).  
Cell cultures are described based on two parameters: origin of the cells and 
manner of growth (suspension or adherent growth). The origin of the cells can be: 
- Primary cell culture (from animal or plant tissue) – cells derived directly 
from tissue and usually die after 50 divisions. These cells may give rise to a 
cell strain (a lineage of cells originated from one primary culture) or be 
immortalized (Ryan, 2008); 
- Extended culture (multi passage culture – cell strain) – when the cells in the 
primary culture vessel have grown and filled up all of the available culture 
substrate; they must be subcultured to give them more room for continue 
growth (Ryan, 2008); 
- Established (transformed) cell lines. 
The immortalized cells have some advantage over mortal cells: grow indefinitely 
in culture and ―do not die‖. 
Cells grown in suspension proliferate without the attachment to culture container. 
Blood, spleen and bone marrow are some examples. Adherent cells grow as a 
monolayers attached to the surface of culture container. Fibroblasts, epithelial cells or 
neurons are examples of culture cells.  
Cell culture required the following materials (Figure 1): 
- Medium (nutrients, Serum Fetal Bovine- SFB, growth factors, amino acids); 
- Containers with special treatment to adhere cells; 
- Incubator (CO2+air+H2O); 
- Tissue culture hood. 
 5 
 
 
Figure 1: Some material used in cells culture: A – flasks; B – microplates. 
 
The microsystems dedicated for cell engineering should assure optimal growth 
of cells, control of cells migration, adhesion and should also provide optimal 
oxygenation and flow of culture medium (Khademhosseini et al., 2005; Prokop et al., 
2004). 
In order to precisely study cell physiology and functions as well as their 
response to various culture conditions, a physiologically meaningful, well-defined and 
homogenous culture environment is crucial (Wu et al., 2008). 
2.1. Cell Migration 
Cells sense and respond to a wide variety of external physiological and chemical 
signals, integrate such complex incoming signals, and change their morphology, 
dynamics, behaviour, function, and fate (Geiger, Spatz and Bershadsky, 2009). Cell 
movement is one of the fundamental features of living cells. For example, epithelial 
cells migrate during wound healing processes, leukocytes migrate to sites of 
inflammation and infection, vascular endothelial cells migrate to form new capillaries 
during angiogenesis, and cell sheets migrate to form tissues and organs during 
development (Gilbert, 2003; Moser et al., 2004; Singer and Clark, 1999).  
Migration can also contribute to some pathological processes, including vascular 
disease, chronic inflammatory diseases, and tumour formation and metastasis. Thus, 
there is considerable interest in understanding cell migration on a molecular level 
because this could lead to novel therapeutic approaches, especially in areas of 
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biotechnology that focus on cellular transplantation and the manufacture of artificial 
tissues (Horwitz and Webb, 2003). 
Beyond these physiological processes, cell migration is an important aspect of 
cancer metastasis where cancer cells exfoliate from the site of primary tumour 
formation and migrate to other organs within the body through the circulatory and 
lymphatic systems (Hanahan and Weinberg, 2000). Cell migration is inherently a multi-
scale and multidisciplinary process that requires a thorough understanding of both the 
biochemical aspects of cell signalling and chemotaxis, and of the biophysical and 
mechanical aspects of cell-matrix interactions (Zaman et al., 2006). 
There are a couple of types of cell movement that includes random movement 
(chemokinesis), directional migration (chemotaxis), and haptotaxis. Chemotaxis is the 
directed cell movement along a positive concentration gradient of chemoattractants, 
whereas haptotaxis is the cell motility in response to adhesive substrates such as 
extracellular matrix (ECM) (Rikitake and Takai, 2011). In general, cells become 
polarized in response to an extracellular stimulus that causes cells to move in a 
unidirectional manner. In the initial step of cell movement, actin-rich membrane 
protrusions such as filopodia and lamellipodia are extended and peripheral ruffles are 
formed at the leading edge in the direction of migration that results in the formation of 
an asymmetric cell front–rear polarity (Andrew and Insall, 2007; Arrieumerlou and 
Meyer, 2005; Dawe et al,  2003; Petrie, Doyle and Yamada, 2009). Under peripheral 
ruffles, focal complexes are formed and these immature cell–ECM adhesion structures 
are transformed into mature cell–ECM adhesion sites called focal adhesions during cell 
movement (Rikitake and Taiki, 2011). 
Cell migration is a fundamental cellular process that involves the protrusion of 
the leading edge, the formation of new adhesive structures at the front, the contraction 
of the cell, and the release of adhesions at the rear (Rikitake and Taiki, 2011). 
Today, we know that only a small portion of highly specialized cells is able to 
actively and autonomously migrate within the organism. These cells are: stem cells, 
leukocytes, fibroblasts, and tumour cells (Entschladen et al., 2005). 
Typical cell migration assays are initiated by partial physical scraping of cell 
monolayers to mimic cell migration during in vivo wound healing (Sanghavi et al., 1994; 
Niea et al., 2007). Commonly, gradients of molecules were used in the body to regulate 
cell migration, axon extension, angiogenesis, and differentiation. Therefore, controlling 
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the spatial location of molecules on a surface or throughout a material could be 
potentially beneficial for tissue engineering (Kapur and Shoichet, 2004). 
Hydrogels were synthesized with gradients of signalling or adhesive molecules 
or with varying crosslinking density across the material with the ability to direct cell 
behaviour such as migration, adhesion, and differentiation (Burdick, Khademhosseini 
and Langer, 2004; Zaari et al., 2004). 
Migration is not limited to development, but occurs in the adult in both normal 
and pathological states. For example, skin is renewed continuously from precursors that 
migrate up from the basal layer. Migration also functions in the adult in immune 
surveillance, where leukocytes from the circulation migrate into the surrounding tissue 
to ingest bacteria. Tumour formation is accompanied by the invasion of blood vessels 
that arise from the proliferation and migration of their component endothelium. In 
metastatic cancer, some tumour cells acquire the ability to migrate out of the initial 
tumour into the circulation and move to new locations where they form a secondary 
tumour (Horwitz and Webb, 2003). 
Recent evidence is pointing to plasticity in migration mechanisms. For example, 
the migration of cells in vivo differs from that of cells migrating in vitro. Migration in 
vivo is much more directed than that in vitro with cells forming long, stable protrusions 
pointed in the direction of migration. Tumour cells also show a plasticity that depends 
dramatically on the environment. Under some conditions they polarize and migrate 
along collagen bundles, whereas under others, they become more amoeboid and use 
different migration mechanisms (Horwitz and Webb, 2003). 
Stem cells recently came into focus for migration studies, as researchers 
recognized that stem cells do not only reside in the tissue, e.g. the bone marrow, but 
actively migrate to certain areas of tissue regeneration such as the liver (Kollet et al., 
2003; Masson et al., 2004). 
2.2. Application of culture cells  
Culture cells can be used in a diversity of applications, for example, in drug tests, 
chemical and biochemical assays. 
2.2.1. Dimensional and tridimensional culture 
Cells grow through interactions and communication with other cells within the 
living organisms that have complex and well-organized two-dimensional (2D) or three-
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dimensional (3D) microscale systems composed of multilayers, membranes, protein 
channels, and many other elements (Yeon and Park, 2007). 
Cells in their natural in vivo surroundings are exposed to a complex chemical 
and structural environment. The natural extracellular matrix is made up of structural 
components that are of nanoscale dimensions. Major fibrous extracellular molecules 
such as collagen fibers, elastin fibers, keratin fibers, and other have nanoscale diameters. 
It is highly important to mimic the natural environment when culture cells in vitro 
because cell behaviour is determined by both genetic make-up and the surrounding 
environmental cues. Cellular behaviours such as proliferation, differentiation, 
morphology, and migration are commonly controlled in culture by modulation of the 
chemical environment (Beachley and Wen, 2010). 
Cell migration studies have focused primarily on migration in 2D environments, 
including a number of modeling endeavors (DiMilla, Barbee and Lauffenburger, 1991) 
over the past 20 years. Though these 2D analyses give us a fair insight on the mechanics 
of cell-substrate and cell-cell interactions, yet they still fall short of explaining the 
comprehensive in vivo processes due to lack of the 3D (Friedl and Brocker, 2000; Friedl 
and Wolf, 2003). 
When cells migrate through 3D matrices they experience resistance through 
biophysical interactions with the visco-elastic matrix. This resistance is a unique feature 
of motility in 3D, as in the case of 2D motility, resistance is limited to interfacial 2D 
friction. In order to overcome this resistance the cells follow a sequence of adhesion and 
detachment events facilitated by the cell surface receptors (Friedl and Brocker, 2000; 
Wolf et al., 2003). 
Fibrillar topographical cues in the form of 1D nanofibres can guide axonal 
growth and glial cell migration in vivo (Schnell et al., 2007; Tysseling-Mattiace et al., 
2008). After spinal cord injury, the failure of axons to regenerate, results in paralysis. 
This clinical problem is due partially to the inability of axons to traverse scar tissue 
generated locally by glial cell infiltration into the wound that physically blocks axon 
regeneration (Tysseling-Mattiace et al., 2008). Immediately after a spinal cord injury in 
an animal model, introduction of peptide amphiphile molecules that self-assemble into 
nanofibres reduces glial scarring and promotes motor and sensory neuron outgrowth 
through the wounded region. While more investigation is required to understand how 
topographic physical cues are involved in directional migration in vivo, it is clear that 
association of cells with ECM with a defined structure, whether a 2D surface, a 3D 
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matrix, or a 1D line/nanofibre, can strongly affect cell polarity, cell morphology and cell 
migration (Petrie, Doyle and Yamada, 2009). 
In vitro experiments show that parallel collagen fibres radiating outward from 
tumour explants can promote tumour epithelial cell invasion, while non-linear matrix 
reduces invasive behaviour (Provenzano et al., 2008). Tumour cells remodel the matrix 
into these parallel fibres in order to migrate. These data suggest that oriented ECMs 
play a role in vivo in directional migration and invasion. Understanding these 
mechanisms may provide better models for cancer metastasis and developmental 
processes (Petrie, Doyle and Yamada, 2009). 
Recently, there has been increasing interest in culture in a 3D environment, 
predominantly in the areas of basic cell biology and drug testing. This is mainly because 
researchers are recognizing the limitations of 2D cultures, given the fact that they do not 
reproduce the morphology and biochemical features that the cells possess in the original 
tissue (Baharvand et al., 2006; Benya and Shaffer, 1982; Pardon et al., 2000). 
It is well established that cells in a 2D culture environment physiologically differ 
from ones in a 3D architecture (Baharvand et al., 2006; Benya and Shaffer, 1982; 
Pardon et al., 2000). For example, articular chondrocytes lose their phenotypic 
characteristics in a 2D culture condition, whereas their biological functions are restored 
when the 2D cultured cells are transferred to a 3D environment (Benya and Shaffer, 
1982). Consequently, it is of great interest to use 3D culture models, where cells are 
seeded in a 3D scaffold, to better mimic the in vivo conditions (Wu et al., 2008). 
Many cell types, including tumour cells, chondrocytes, and embryonic stem cells, 
require a 3D microenvironment to properly demonstrate their in vivo physiology 
(Behravesh et al., 2005; Abbott, 2003; Birgersdotter, Sandberg and Ernberg, 2005; 
Camps et al., 2002; Cukierman et al., 2001; Levenberg et al., 2003; Martin et al., 2001; 
Mueller-Klieser, 1997).  
2.3. Tumour cells lines 
HeLa is an immortal cell line used in scientific research. It is the oldest and most 
commonly used human cell line, and it was derived from cervical cancer cells taken 
from Henrietta Lacks (Rahbari et al., 2009; Scherer, Syverton and Gey, 1953). 
There are many different cell lines and some examples are shown in Table 1:  
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Table 1: Examples of some different human cell lines. 
Human cell lines Cell name Description 
Breast  MCF-7
1
 Human breast carcinoma cell line 
Colon  COLO-205
1
 Human colon adenocarcinoma cell line 
Skin  MEL-CLS-2
1
 Human skin melanoma cell line 
Bone  HOS
1
 Human osteosarcoma cell line 
Liver  HEP-G2
1
 Human hepatoma cell line 
Leukemia  HL-60
1
 Human acute myelocytic leukemia (AML) 
cell line 
Lung  NCI-H146
1
 Human lung small cell carcinoma cell line 
NCI-H460
2
 Human lung large cell carcinoma cell line 
Stomach  AGS
1
 Human stomach adenocarcinoma cell line 
Kidney  769-P
1
 Human kidney carcinoma cell line 
Colon HCT 116 (CCL-
247)
2
 
Human colorectal carcinoma 
HCT-15
3
 Human colon adenocarcinoma 
 
The tumour cell lines have the advantage of being immortal. So, it is possible to 
replicate tumour cells indefinitely in time. Using mortal cell lines, the number of 
replications is limited to 50, which for drug tests may not be enough. 
 
  
                                                 
1
 http://www.cell-lines-service.de/content/index_eng.html 
2
 http://www.lgcstandards-atcc.org/ ATCCCulturesandProducts/ 
CellBiology/CellLinesandHybridomas/tabid/981/Default.aspx  
3
 http://www.hpacultures.org.uk/products/celllines/generalcell/ 
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3. Blood Cells 
The main constituents of blood are red blood cells (RBCs), white blood cells 
(WBCs), platelets and plasma. Plasma and RBCs are the biggest part of its constituents. 
RBCs or erythrocytes do not have nuclei and their main function is oxygen transport. 
WBCs or leukocytes have nuclei and subdivide in lymphocytes, granulocytes and 
macrophages. Leukocytes are the first immune response of our organism. Platelets or 
thrombocytes do not have nuclei and their function is the close of ruptures in vascular 
walls. At last, plasma is composed mostly with water, sugars and proteins. Its function 
is carrier nutrients, RBCs, white cells and platelets. 
In microcirculation, which comprises the smallest arteries and veins, the flow 
behaviour of individual blood cells and their interactions provide the microrheological 
basis of flow properties of blood at a macroscopic level. As a result, in microcirculation 
it is fundamental to study the flow behaviour of blood at cellular level. Thus, blood is 
not a homogeneous fluid, but one composed by a suspension of cells, proteins and ions 
in plasma. In normal blood, three types of cells comprise about 46% of its volume. 
These cells are RBCs representing 45% of volume, WBCs and platelets (Figure 2) 
(Garcia, Dias and Lima, 2012). 
 
Figure 2: Red blood cells, white blood cells and platelets (adapted of Discover Magazine). 
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3.1. Erythrocytes deformation 
RBC deformability is the ability of RBC to deform under applied stresses, which 
is important for the delivery of oxygen to tissues. In vitro blood flow behaviour in 
microchannels is strongly influenced by the RBCs, since they occupy almost half of 
whole blood volume (Lima et al., 2012). Important factors that determine RBC 
deformability include the cell volume to surface area ratio, the viscosity of the 
cytoplasm, and the elastic behaviour of its membrane (Mohandas and Chasis, 1993; 
Mohandas and Evans, 1994). RBCs are formed in the bone marrow and during 
maturation they lose their nuclei before entering the circulatory system. When 
suspended in an isotonic medium, RBCs have a biconcave discoid shape, with a major 
diameter of about 8 μm. The density of a RBC is about 1.08x103 kg.m-3 and its major 
cellular components are the cytoplasm and a thin membrane composed of lipid bilayer 
and protein molecules that together determine its elastic properties (Evans, 1973; Evans 
and La Celle, 1975; Lima et al., 2012). There is experimental evidence that healthy 
RBCs are extremely deformable into a variety of shapes in flowing blood in response to 
hydrodynamic stresses acting on them (Lima et al., 2012). The RBCs elongate 
significantly when they pass through capillaries, the diameter of which is smaller than 
the diameter of RBCs at rest (Caro et al., 1978; Hardeman and Ince, 1999). 
Early studies of micropipette aspiration of the RBC have already indicated the 
crucial role that membrane shear deformation plays in RBC deformability (Evans 1973; 
Evans and La Celle 1975). These analyses were performed under the assumption that 
the skeleton is incompressible. However, Discher et al. (1994), using fluorescence to 
image the deformation of the skeleton, demonstrated that the skeletal density of the 
pipette-aspirated membrane is non-uniform. Based on this evidence, Mohandas and 
Evans (1994) and Boey et al. (1998) developed elastic constitutive models of the 
membrane that account for the skeleton area expansion. 
The deformability can have serious consequences leading to health problems 
(Cho, Mooney and Cho, 2008). In fact, it has been suggested to certain diseases and 
therefore determination of RBC deformability may be an important tool in medical 
diagnosis (Hardeman and Ince, 1999; Hou, et al., 2010; Tsukadaet al., 2001).  
So far, many investigations on human RBC deformability have been performed 
using a variety of techniques, including optical tweezers and micropipeting (Musielak, 
2009; Shin et al., 2007).  
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Important studies in biomicrofluidics devoted to blood rheology and its flow 
dynamics in microchannels, which have played a key role in several recent 
developments of lab-on-chip devices for blood sampling, analysis, and cell culture 
(Abkarian, et al., 2008; Chau, Rolfe and Cooper-White, 2011; Faivre et al., 2006; 
Fujiwara, et al., 2009; Nakano, et al., 2010). 
Researchers, such as Shevkoplyas et al. (2005, 2006) Yang et al. (2006) and 
Faivre et al. (2006) took advantage of the natural flow properties of blood in 
microcirculation, such as plasma skimming, leukocyte marginalization, the bifurcation 
law, and cell-free layer enhancement by an abrupt constriction, to design microfluidic 
devices to separate plasma and leukocytes from the whole blood. 
The complexity of controlling and obtaining detailed measurements of the blood 
flow behaviour through in vivo microvascular systems (Nakano et al., 2005) has led to 
in vitro studies being performed by using polydimethylsiloxane (PDMS) microchannels 
obtained by means of a soft-lithography technique (Ishikawa, et al., 2011; Lima, et al., 
2011; Shevkoplyas et al., 2005; Shevkoplyas et al., 2006;). 
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4. Microfabrication 
Microfabrication such as micromachining, micromanufacturing or micro 
eletromechanical system (MEMS) is a technique used in fabrication of devices with 
very small dimensions in the micrometer range (Madou, 2002). Soft lithography is a set 
of microfabrication techniques that use elastomeric stamps fabricated from patterned 
silicon wafers to print or mould materials at resolutions as low as several hundred 
nanometers (Kane et al., 1999; Ostuni et al., 2001; Ostuni, Yan and Whitesides, 1999; 
Xia and Whitesides, 1998A). 
In the past few years, microfabrication has been increasingly used in biomedical, 
biochemical and biological applications, for both fundamental research and device 
application, altogether called BioMEMS (Madou, 2002; Whitesides et al., 2001; Ziaie et 
al., 2004).  
Principal advantages to use the BioMEMS techniques are (Duffy et al., 1998; 
Madou, 2002;Ziaie et al., 2004; ): 
a) Obtain small dimensions with high resolution and sensitivity; 
b) Ability to incorporate sensing and actuating functions in proximity or on the 
same substrate; 
c) Ability to incorporate, probe, manipulate, and study molecules and cells; 
d) Minimal invasiveness; 
e) Portability; 
f) Shorter analysis time; and  
g) Ability to facilitate high-throughput experimentations due to redundancy and 
arrays.  
Microtechnology can facilitate the study of cell behaviour in vitro because it 
provides the necessary tools for recreating in vivo-like microenvironments (Walker et al., 
2004). Therefore, microfluidic devices for cell culture studies are rapidly gaining 
importance in drug development and biological research applications, such as drug 
toxicity or metabolism studies, and stem cell differentiation studies (Toh et al., 2007). 
Microfabrication is separate in two categories: hard micromachining (using hard 
materials like silicon, glass and metal) and soft micromachining (using soft material like 
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polymer and gels) (Ziaie et al., 2004). The most important steps used by the two 
categories are shown in Table 2. 
 
Table 2: Steps of hard and soft micromachining (Campbell, 2001; Jaeger, 2002; Xia and Whitesides, 
1998A; Ziaie et al., 2004) 
Hard micromachining Soft micromachining or soft 
lithography 
Thin film deposition Micromolding 
Lithography Hot embossing 
Etching Microcontact printing 
Substrate bonding  
 
4.1. Photolithography 
Photolithography has some typical steps (Li, Tourovskaia and Folch, 2003; Wen, 
2009): 
a) 2D pattern is first created with a computer-aided design software; 
b) Photomask is then generated following the CAD design; 
c) After thin-film deposition of the desired material on a silicon wafer, a thin 
and uniform layer of photoresist is spin coated, Figure 3A;  
d) Coated wafer is soft baked, removing the solvents and enhancing adhesion; 
e) Wafer is exposed to UV (ultraviolet) light under the photomask, Figure 3B; 
f) Unpolymerized photoresist is dissolved off the wafer; 
g) Hard bake is used to further improve the adhesion and concludes the process.  
The process is basically as shown in Figure 3.  
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Figure 3: General process flow in photolithography (adapted from Li, Tourovskaia and Folch, 2003). 
An important lithography step is the photoresist. The composition of a 
photoresist is a polymer (base resin which changes structure upon radiation), a sensitizer 
(controlling the photochemical reactions in the polymer), and a casting solvent 
(allowing thin layer formation by spin coating). There are two types of photoresist in 
response to UV exposure. One is called positive tone (for example PMMA), (Madou, 
2002). The most common negative photoresist is SU-8 epoxy, invented by IBM 
scientists. SU-8 is composed of EPON SU-8 resin and a photosensitizer triaryl 
sulfonium salt (Angelo et al., 1992; Lee et al., 1995). SU-8 resist is specifically 
designed for micromachining for thick films up to 500 μm in a single coat and has 
excellent sensitivity, high resolution, low optical absorption, high aspect ratios, and 
good thermal and chemical stability, with low cost (Bertsch, Lorenz, Renaud, 1999; 
Madou, 2002). 
Spin coating is achieved by dispensing a viscous solution of resist onto the wafer 
placed on a vacuum chuck. Then the wafer is spun at a high speed, ranging from 1500 
to 8000 rpm, depending on the viscosity and the desired thickness, to form a uniform 
film of photoresist. This is a critical step to ensure the success of pattern transfer, which 
should be done with extreme care to eliminate defects and ensure uniformity. After spin 
coating, a soft baking ensues at 75 to 100 ºC for, say, 20 min to evaporate the solvent 
and to remove the built-in stress, in order to enhance the adhesion of the resist to the 
silicon wafer (Wen, 2009). 
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The unpolymerized photoresist needs to be washed away from the wafer, leaving 
the desired latent features to stand out, which may be used as a mask for further 
subtractive or additive steps or as a mold for pattern transfer with soft lithography. 
There are two major technologies for development: wet development and dry 
development. The first is widely used in microfabricatioin in general, and the latter is 
beginning to substitute wet development for applications with fine line width resolution. 
Dry development is devised to overcome some disadvantages of wet development, such 
as some swelling of the resist in organic solvents and loss of adhesion. However, dry 
developed resists should be used (Madou, 2002). 
Soft materials, such as polymers and gels, are amenable to a series of 
micromolding techniques under relatively mild conditions, such as replica molding 
(REM), microtransfer molding (μTM), micromolding in capillaries (MIMIC), and 
solvent-assisted micromolding (SAMIM), Figure 4 (Wen, 2009).  
 
Figure 4: Schematic illustration of micromolding techniques. A) replica molding, B) microtransfer 
molding, C) micromolding in capillaries, and D) solvent-assisted micromolding (Xia and Whitesides, 
1998A). 
Replica molding duplicates the shape, the morphology, and the structure from a 
master. It has the capability of 3D pattern transfer in one step, whereas photolithography 
does not have this capability. The process is reliable, fast, simple and inexpensive with a 
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resolution as small as below 100 nm for which photolithography runs to its limit due to 
optical diffraction (Madou, 2002; Xia and Whitesides, 1998A). 
In μTM, a drop of prepolymer is applied on the surface of an elastic master and 
the excess liquid is removed, which is followed by placing it against a substrate. After 
the prepolymer is cured and the master is removed, a patterned microstructure is left on 
the surface of the substrate (Zhao, Xia and Walker, 1996). Both isolated and 
interconnected microstructures may be obtained through μTM with the advantage over 
other microfabrication techniques that microstructures may be transferred to nonplanar 
surfaces, which facilitates the fabrication of multiple layers of 3D structures (Xia and 
Whitesides, 1998A).  
In MIMIC elastomeric master is placed in conformal contact with the substrate, 
leaving the interconnected microfeatures to form a network. Then a low-viscosity pre-
polymer is applied at the open ends of the network and sipped in by capillary force. 
After curing of the precursor and the removal of the master, an interconnected 
microstructure may be formed on the substrate surface. MIMIC is a convenient 
microfabrication technique (Xia and Whitesides, 1998A).   
SAMIM shares some characteristics of replica mold and embossing. In SAMIM, 
an elastomeric master is wetted with a solvent that well dissolves the substrate polymer 
but not the master, and brought into contact with the substrate. The solvent swells a thin 
layer of the polymer, in which the microstructures may be generated according to the 
master‘s topology. The success of SAMIM depends on the choice of the solvent, which 
not only should have selectivity in dissolution but also should have high gas pressure. 
The SAMIM procedure is a simple technique to form complex quasi-3D features in one 
step. It is different from commonly used hot embossing, in that it uses solvent to soften 
the polymer substrate instead of heat, and the master is elastomer instead of hard 
materials (Xia and Whitesides, 1998A). 
Both techniques (hard and soft micromachining) need a clean room to do some 
processes, because this is sensitive procedures and all carefully are necessary. Table 3 
presents the classifications of clean rooms. 
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Table 3: Clean room classifications (adapted of Data Recovery). 
Class Maximum number of particles per cubic foot 
of air of diameter greater than or equal to 
each indicated size 
Typical uses 
0.1 µm  0.2 µm  0.3 µm  0.5 µm  5.0 µm 
1  35  7.5  3   1  —  integrated circuits 
manufacturing 10 350  75  30   10  — 
100  —  7502  300   100 —  hard drive manufacturing 
 hard drive data recovery 
 miniature ball bearings 
assembly photo labs 
 medical implants 
1000 — — — 1000  7  pharmaceutical 
manufacturing 
10000 —  —  — 10000  70  colour TV tubes 
 hospital operating room 
100000 — — — 100000 700  ball bearings 
 
4.2. PDMS 
PDMS is a silicone elastomer and has been the most popular soft material in 
biomedical microfabrication applications due to very suitable physical and chemical 
properties, Table 4 (Makamba, et al. 2003; McDonald and Whitesides, 2002; Toepke 
and Beebe, 2006).  
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Table 4: Physical and chemical properties of PDMS (Adapted from McDonald and Whitesides, 2002). 
Property Characteristic Consequence 
Optical Transparent;  
UV cut off, 240nm. 
Optical detection from 240 to 1100 
nm. 
Electrical Insulating: breakdown 
voltage, 2e7V/m 
Allows embedded circuits; 
Intentional breakdown to open 
connections. 
Mechanical Elastomeric;  
tunable Young‘s modulus, 
typical value of ~750kPa 
Conforms to surfaces;  
allows actuation by reversible 
deformation; 
Facilitates release from moulds. 
Thermal Insulating;  
thermal conductivity 
0.2W/(m.K);  
coefficient of thermal 
expansion, 310μm/(m.ºC) 
Can be used to insulate heated 
solutions;  
does not allow dissipation of resistive 
heating from electrophoretic 
separation 
Interfacial Low surface free energy ~20 
erg/cm2 
contact angle of Sylgard-184: 
~110º 
Replicas release easily from moulds; 
can be reversibly sealed to materials 
Permeability Impermeable to liquid water; 
permeable to gases and 
nonpolar organic solvents; 
oxygen diffusion coefficient 
3.55×10-5 cm2/s 
Contains aqueous solutions in 
channels;  
allow gas transport through the bulk 
material;  
incompatible with many organic 
solvents 
Reactivity Inert;  
can be oxidized by exposure 
to a plasma;  
Bu4N+F-((TBA)F) 
 
Unreactive toward most reagents; 
surface can be etched;  
can be modified to be hydrophilic and 
also reactive toward silanes; etching 
with (TBA)F can alter topography of 
surfaces 
Toxicity Nontoxic can be implanted in vivo;  
supports mammalian cell growth 
 
The porous nature of PDMS is convenient for cell-based studies, because it 
allows oxygen and carbon dioxide to freely diffuse through it (Makamba et al., 2003; 
Toepke and Beebe, 2006). 
PDMS has been the most popular material in microfluidics community as it is 
optically transparent, chemically inert, biologically compatible, inexpensive and easy to 
pattern by soft lithography (Li, Tourovskaia and Folch, 2003; Makamba, et al. 2003; 
Toepke and Beebe, 2006). These properties may be translated to the following 
important operation advantages:  
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a) PDMS has high fidelity in pattern transfer down to 10‘s of nm (McDonald 
and Whitesides, 2002); 
b) It is an elastomer which has superior conformability to other surfaces and 
may be actuated for making microfluidic components, such as pumps and 
valves (Berg et al., 2003; Grover et al., 2006; Thorsen, Maerkl and Quake, 
2002);  
c) It has good sealing with itself and other surfaces, both reversibly and 
irreversibly, such as silicon, glass, polystyrene, polyethylene, or silicon 
nitride, provided both the surfaces are treated with oxygen or air plasma for 
about  one minute (Chaudhury and Whitesides, 1991; Li, Tourovskaia and 
Folch, 2003; McDonald et al., 2000) or exposed to UV/ozone (Efimenko, 
Wallace, and Genzer, 2002), for irreversible sealing; 
d) PDMS may form complex 3D networks by stacking multiple layers in 
alignment due to its transparency and good sealing (Anderson et al., 2000); 
e) PDMS is highly permeable to gases, especially nonpolar gases, such as O2, 
N2 and CO2 (Charati and Stern, 1998; Erdodi and Kennedy, 2005; 
Whitesides et al., 2001), which facilitates cell-based applications. 
However, PDMS is hydrophobic, which may constitute some challenges in 
microfluidic applications due to capillary pressure (Whitesides et al., 2001). But the 
surface of PDMS may be rendered hydrophilic by strong oxidants, such as oxygen 
plasma or UV/ozone, with comparably limited degrees, but may recover to hydrophobic 
in a few minutes in the air. Storage in water may slow the recovery process. In addition, 
PDMS is prone to protein adsorption and biofouling (Wen, 2009). 
The most widely used PDMS is Sylgard 184 silicone elastomer kit from Dow 
Corning, composed of a base and curing agent. When forming the elastomer, the liquid 
prepolymer base and the catalytic curing agent is mixed by a ratio of about 10:1 and 
heated to about 70ºC for 2 hours (Wen, 2009).  
One of the major drawbacks of PDMS film is that its surface is highly 
hydrophobic in nature with very low surface energy (Morent et al., 2007) which greatly 
impedes its usage without undergoing appropriate surface modification. This property 
of PDMS poses serious problem in various applications like reliable PDMS–PDMS 
bonding (Bhattacharya et al., 2005) in microvalves and micropumps (Jeon et al., 2002; 
Yang and Lin, 2007), fluid flow through microfluidic channels in electrokinetic 
applications (Vickers, Caulum and Henry, 2006), attachment of animal cells for cell 
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culture (Wu, 2009), deposition of metal thin films for realization of microelectrodes and 
microcircuit connections in flexible electronics (Axisa et al., 2007; Lacour, Tsay and 
Wagner, 2004; Morent et al., 2007). Thus, it is important to modify the PDMS surface 
for successful realization of such microdevices. 
A variety of solutions, primarily surface modifications, have been proposed, for 
example, oxygen plasma treatment, silanization, adsorbed coatings (Polybrene/dextran 
sulfate), and protein or lipid coatings (Duffy et al., 1998; Barker et al., 2000; 
Grzybowski et al., 1998; Linder et al., 2001; Liu, et al., 2000). However, surface 
modifications such as oxygen plasma treatment and adsorbed coatings can be unstable 
requiring periodic reapplication. 
Protein-based coatings frequently result in ill-defined and heterogeneous surface 
properties as proteins are attached in a multiplicity of orientations with some molecules 
denatured and others folded (Hu et al., 2002). 
Some hybrid microdevices (i.e. PDMS/glass) were also fabricated, e.g. a 
microsystem dedicated for growing and monitoring of cell lines and testing their 
exposure to drug or toxin (Hung et al., 2004; Prokop et al., 2004). 
4.2.1. Surface modification of PDMS 
Surface modification techniques include the dry method: activation of PDMS 
surface with air/oxygen/argon, UV/Ozone and corona discharge technique. The wet 
method includes: deposition of a suitable layer over the PDMS surface through physical 
adsorption of charged amphiphilic molecules, copolymer layer, layer-by-layer (LBL) 
self-assembly or through chemical modification using self-assembled monolayers 
(SAM), UV grafting or direct treatment with reactive chemicals like piranha solution 
(Maji, 2012). 
Maji, Lahiri and Das (2012) studied the hydrophilicity of PDMS using the 
piranha and potassium hydroxide (KOH) with good results for time treatment equal 15 
minutes where the measured of contact water was 27º.  
PDMS is hydrophobic and this characteristic has a crucial importance when we 
work with cells, because cells are almost water. So, the PDMS repels the cell and it is 
not possible the attachment and proliferation in this conditions.  
For this problem, some researchers choose different techniques like oxygen 
plasma, UV-grafting, piranha and KOH solution. 
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The methods for surface modification can be divide in two categories, the dry 
methods that include air/oxygen/argon plasma, UV/Ozone and corona discharge 
technique, and the wet methods, that include deposition od a suitable layer, copolymer 
layer, layer-by-layer (LBL) self-assembly and chemical modifications like SAM, UV-
grafting (Hu et al., 2002) and piranha solution (Maji, Lahari and Das, 2011). 
Oxygen plasma is the option of most researchers, but have more cost 
comparative with others. For example the piranha solution has a low cost and this 
preparation is very simple and results are in the majority of cases the same as oxygen 
plasma. 
4.2.1.1. Adhere microdevices on different substrates  
Building a microfluidic device presents some challenges. Sometimes is difficult 
the union of the device to a substrate; it is necessary to pay attention which materials are 
used. In this case the main materials of microdevices and substrates are PDMS/glass 
and PDMS/PDMS, because it is necessary a clear view for the cell observation. 
Depending of the device objective two options exist: reversible bonding or irreversible 
bonding. 
The irreversible bonding is a definitive attach of the materials and methods like 
oxygen plasma or UV/ozone were used (Efimenko, Wallace and Genzer, 2002). These 
methods affect the surface properties of the substrates.  
The irreversible bonding is a non-definitive attach of the materials. Some 
researchers like Wen use a technique of reversible packing which is a method of frame-
assisted assembly (FAA), Figure 5.  
 
Figure 5: Reversible packing with wholes to insert the screws and inlets for the microfluidic device 
(adapted from Wen, 2009). 
Liu et al. (2009) tried another strategy to sealing the device with scotch tape. In 
this case, it was possible to use the mentioned method because their project did not 
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involve cells. Their device was for immunoassays and used proteins. The tape could be 
toxic for cells and kill them.  
4.3. Microfluidics  
With the help of recent advances in microfluidic technology, a cell culture 
system can be miniaturized into a microfluidic device, which can largely minimize the 
chemical gradient phenomena existing in culture environments and cultured constructs 
and hence provides better control over the cells‘ microenvironments (Wu et al., 2006). It 
also reduces the number of cells required and the need for large volumes of culture 
medium and costly reagents. 
Microfluidic systems have been developed by several groups to attempt to create 
microenvironments of greater physiological relevance and high-throughput platforms 
for cell behaviour analysis (Walker, Zeringue and Beebe, 2004). 
While traditional non-microfluidic (static) cultures can be straightforwardly 
maintained by occasional medium replacements, microfluidic cultures cannot be treated 
as static because the average volume of medium per cell is typically one order of 
magnitude smaller than in macroscopic cultures (Tourovskaia, Figueroa-Masot and 
Albert Folch, 2004), Figure 6. 
 
Figure 6: Two different culture cells. A – Microfluidic culture with dynamic flux; B – Microplate for 
culture with PDMS to seal the top (Wen, 2009). 
Miniaturization has started to play an important role in genomics and proteomics, 
clinical diagnostic in medical sciences, pharmacology, tissue engineering and cell 
biology (Khademhosseini et al., 2005). 
Microfluidic chambers enable spatial and temporal control of solubilized factors 
such as oxygen and nutrients, allowing for a more realistic replication of the complex 
conditions found in vivo than in conventional cell-culture set-ups (Hu, Quaranta and Li, 
2007). 
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The typical microfluidic channel has a minimum dimension on the scale of 1 to 
1,000 µm. A standard microfluidic network may consist of a set of 10 interconnected 
channels, each 100 µm in height and width, and 10 mm in length, giving a total fluid 
volume of 1 µl. On this scale, it is important to consider the fluid mechanics and mass 
transport differences in comparison with a standard culture dish (a 60 mm culture dish 
has no flow, and roughly 4,000 µl of volume) (Lee, Gaige and  Hung, 2011). 
In addition, micro scale technologies allow for an unprecedented ability to 
control the cellular microenvironment in culture and miniaturize assays for high-
throughput applications (Khademhosseini et al., 2005). 
4.3.1. Microfabricated device for cells 
Microfabricated devices create unprecedented opportunities to study and utilize 
biological cells (El-Ali, Sorger and Jensen, 2006), with unique advantages of highly 
tailor able microenvironment that is of cellular relevant dimensions (from nm to μm) 
and of highly parallel experimentation that may generate abundant information. 
Therefore, the techniques for culturing, stimulation, handling, and analysis for cells at 
microscale have made tremendous progress since their combination, making microscale 
systematic cell-based studies possible, but still with substantial challenges in fabrication, 
integration and packaging (Wen, 2009). 
Cells are fragile and sensitive, and their good maintaining and growth are 
usually the starting point for further experiments. Microfabricated devices for cell 
culture, cell monitoring and cell-based assay have tremendous advantages with high-
throughput and high-content capabilities. There are three major driving forces for 
developing such systems: tissue engineering, cell-based assays, and bioprocess 
parameter characterization (Wen, 2009). 
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5. Tissue Engineering 
The term "tissue engineering" has emerged at a meeting sponsored by the 
National Science Foundation (NSF) in 1987. Other definitions exist: Langer and 
Vacanti (1993) defined tissue engineering as "an interdisciplinary field that applies the 
principles of engineering and the life sciences toward the development of biological 
substitutes that restore, maintain or improve tissue function." Galletti, Hellman, and 
Nerem (1995) defined tissue engineering as "the basic science and development of 
biological substitutes for implantation into the body or the fostering of tissue 
remodelling for the purpose of replacing, repairing, regenerating, reconstructing, or 
enhancing function." These subsequent definitions essentially reiterate the NSF 
definition. Two other recently popular terms, regenerative medicine and reparative 
biology, have considerable, sometimes total, overlap with the aims and goals of tissue 
engineering. 
Tissue engineering has emerged as an attempt to resolve the short age in tissues 
and organs for transplantation therapy, by developing tools for biological substitutes 
that would repair and replace damaged tissues and organs in the body (Cima et al., 1991; 
Khademhosseini et al., 2005; Langer and Vacanti, 1993; Nerem, 1991). 
One of the major challenges for tissue engineering is to create a favourable 
environment for the proliferation and differentiation of cells into functioning tissues. 
Three main elements compose engineered tissue, namely the scaffold, the cells and the 
environment in which the cell-scaffold constructs are cultured and conditioned. The 
design and function of synthetic scaffolds can be optimized, allowing for control of cell 
behaviour following seeding onto a final product. Numerous scaffold properties can be 
manipulated, including the type of material utilized, the shape and size of pores in 
which cells are located, the mechanical integrity of the construction, substrate coating 
aimed towards promotion of cell adhesion and incorporation of chemicals and growth 
factors conducive to optimized tissue formation and function (El Haj et al., 2005). 
In general, there are three main approaches to tissue engineering: (i) to use 
isolated cells or cell substitutes as cellular replacement parts, (ii) to use a cellular 
biomaterials capable of inducing tissue regeneration, and (iii) to use a combination of 
cells and materials (typically in the form of scaffolds) (Griffith and Naughton, 2002). 
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Figure 7 shows the various approaches in tissue engineering using cells, scaffolds, or 
their combination. 
 
 
Figure 7: Diagram showing the various approaches in tissue engineering using cells, scaffolds, or their 
combination (Levenberg and Langer, 2004). 
Generally, it is considered that there is a triad of key factors on tissue 
engineering (Lanza, Langer and Vacanti, 2000), which are cells, tissue-inducing 
substances and scaffolds. Following this line, another critical factor, bioreactors, is 
counted in to make this group a quartet (Wen, 2009). 
5.1. Cells 
Recently, there has been increasing interest in culturing in a 3D environment, 
predominantly in the areas of basic cell biology and drug testing. This is mainly because 
researchers are recognizing the limitations of 2D cultures, given the fact that they do not 
reproduce the morphology and biochemical features that the cells possess in the original 
tissue (Baharvand et al., 2006; Pardon et al., 2000). 
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Cells are placed on or within porous matrices, which could be naturally 
originated, such as collagen and fibrin, or synthetic, such as polymers. For synthetic 
polymer scaffold materials, it has been found that the bulk material, 3D morphology, 
structure, porosity, surface chemistry and mechanical properties of scaffolds need to be 
specifically designed and processed to facilitate cell proliferation, migration and 
function (Griffith, 2000; Muschler, Nakamoto and Griffith, 2004). The methods for 
fabricating porous scaffolds include particulate leaching, freeze-drying, gas infusion, 
and phase separation, etc, which generally create isotropic microstructures (Muschler, 
Nakamoto and Griffith, 2004; Yang et al., 2001). There are also novel techniques to 
make scaffolds with designed microstructures, such as solid-free-form fabrication 
methods (e.g. three-dimensional printing process and stereolithography) (Griffith and 
Naughton, 2002; Landers et al., 2002) and multi-layer scaffolds with well-defined 
dimensions using microembossing and carbon dioxide bonding (Yang et al., 2005). 
When cells are not directly incorporated into a nanofiber scaffold, the scaffold 
may be populated by cells that migrate into the interior of the scaffold from the outer 
surface. The extent of cell migration into nanofiber scaffolds can be affected by both the 
architecture of the scaffolds and the biological or chemical cues incorporated into the 
scaffold (Beachley and Wen, 2009). 
Cell migration is a critical process in determining the success of tissue 
regeneration. In many designs, tissue scaffolds are populated by cells due to cell 
migration, either from cells seeded on the scaffold surface in vitro or endogenous cell 
migration in vivo. Tissue engineering scaffolds designed with controlled conduction of 
cell migration are desirable, and nanofibrous architecture can have a significant effect 
on cell migration properties in vitro and in vivo (Beachley and Wen, 2010). 
For cell migration into a nanofibrous scaffold occur there must be adequate void 
space for cells to occupy and move around. In the case of randomly aligned electrospun 
mats, pore size is generally related to fiber diameter, where scaffolds fabricated from 
larger fibers have larger pores and thus greater permeability to cell infiltration (Eichhorn 
and Sampson, 2005). Optimal pore size may be dependent on the specific cell type or 
application, but the minimum pore size necessary for infiltration must not be 
significantly smaller than that of the migrating cells. The trade-off between scaffold 
porosity and fiber diameter in electrospun scaffolds is one  
of the current limiting factors of this technology in tissue engineering (Beachley and 
Wen, 2009). 
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For cell-based tissue engineering, isolated cells are the raw material. So far 
virtually every mammalian tissue has been attempted to be tissue engineered (Langer 
and Vacanti, 1993). The sources of cells may include autologous cells from the patient, 
allogeneic cells from a human donor, and xenogeneic cells from a different species. 
Each category may also be divided as adult cells or embryonic stem (ES) cells. 
However, the cell sources impose the number one challenge for tissue engineering due 
to the lack of proper cells (Griffith and Naughton,  2002), though there have already 
been skin substitutes developed for successful healing surgeries (Mansbridge et 
al.,1998). There have been high hopes for ES cells, but the source for ES cells itself is a 
controversial problem and possible immunological barriers are not fully explored 
(Griffith and Naughton, 2002). However, adult stem cells, such as bone-marrow stem 
cells and haematopoietic stem cells, or applied together with ex vivo gene therapy 
techniques, have shown huge potentials for various tissue regenerations (Bianco and 
Robey, 2001).  
5.1.1. ADSCs 
ADSCs have a great potential for use in tissue repair and regeneration in the 
field of plastic and reconstructive surgery. Although the current applied strategies for 
adipose tissue engineering have advanced in the past years, complete understanding of 
the mechanisms of interactions among adipose stem cells, growth factors and 
biomaterials in tissue engineering is needed to advance the end goal of developing ‗off-
the-shelf‘ tissue-engineering products. The enthusiasm over what unquestionably 
represents a markedly innovative technique with huge therapeutic potential must be 
balanced, although against stringent standards of scientific and clinical investigation, 
before this new technology has its applications (Sterodimas et al., 2010). 
Stem cells, like ADSCs, because of their pluripotentiality, proliferative 
efficiency, low donor morbinidity and unlimited capacity for self-renewal, project great 
promise for tissue engineering and are expected to allow significant advances for 
distinct reconstructive procedures (Ogawa, 2006; Sterodimas et al., 2010). 
Chemical composition, mechanical stability and 3D architecture of the scaffold 
are crucial factors for tissue engineering with ADSCs. Cellular penetration, sufficient 
proliferation and full differentiation inside the construct after transplantation must be 
guaranteed (Hemmrich and von Heimburg, 2006). The limited materials that are 
currently available as carriers or scaffolds in the field of plastic and reconstructive 
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surgery necessitate the introduction of innovative ‗smart‘ materials that will control 
tissue topology and have surface modifications to stimulate cell attachment, 
differentiation and growth (Sterodimas et al., 2010). 
5.2. Nanofibers scaffolds 
Most nanofibers obtained so far are in non-woven form, which can be useful for 
relatively small number of applications such as filtration (Gibson, Schreuder-Gibson 
and Riven, 1999), tissue scaffolds (Fertala, Han and Ko, 2001), implant coating film 
(Buchko et al., 1999), and wound dressing (Jin et al., 2002). 
When the diameters of polymer fiber materials are shrunk from to submicrons or 
nanometers, there appear several amazing characteristics such as very large surface area 
to volume ratio (this ratio for a nanofiber can be as large as 103 times of that of a 
microfiber), flexibility in surface functionalities, and superior mechanical performance 
(e.g. stiffness and tensile strength) compared with any other known form of the material 
(Huang et al., 2003). 
Many different applications for nanofibers in tissue engineering have been 
explored. Because polymer nanofibers can provide 3D architecture, modulate cell 
behaviour, and have the potential to deliver biomolecules, they are a good candidate for 
a wide variety of tissue engineering applications. Table 5 shows some types of tissue 
and how nanofibers can be applied (Beachley and Wen, 2009).  
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Table 5: Nanofibrous scaffolds for tissue engineering applications (adapted of Beachley and Wen, 2009). 
Tissue 
Type 
Promotion of 
desired behaviours 
from tissue specific 
cells in vitro 
Favorable Structural 
properties for tissue 
specific application 
In vivo models 
 
Bone Osteoblastic and pre-
osteoblastic cells 
Mesenchymal stem 
cells  
Selective pore size  Subcutaneous 
implantation  
Bone Defect-Skull 
Bone defect- Femur 
Vascular Endothelial cells 
Smooth muscle & 
endothelial cells 
Shape & mechanical 
properties 
Epigastric vein graft  
Abdominal aortic graft 
Neural 
 
Brain derived neural 
stem cells  
Dorsal root ganglion 
(DRG)  
DRG & perineural 
membrane derived 
primary neurons  
Shape Severed optic tract  
Spinal cord transaction 
Tubular sciatic nerve 
bridging device 
 
In addition to the structural roles of nanofibers, they may also elicit functional 
responses in cells to migratory and remodelling behaviours. Nanofibrous structure 
induced fibroblasts to increase production of collagenase that degrades the adhesive 
collagen between the scaffold surface and cell membrane, and this lead to the 
hypothesis that the nanofibrous architecture may have been encouraging migratory or 
remodelling behaviour in comparison to a smooth surface (Meng et al., 2009). 
A wide variety of biodegradable and biocompatible polymers have been 
processed to fabricate stereoregulated scaffolds, including synthetic polymers, such as 
poly(lactide) (PLA), poly(glycolide) (PGA) and their copolymers poly(lactide-co-
glycolide) (PLGA), poly(ɛ-caprolactone) (PCL), and natural polymers, such as collagen, 
protein, and fibrinogen (Langer and Tirrell, 2004; Malafaya, Silva and Reis, 2007; 
Sokolsky-Papkov et al., 2007). Table 6 shows some materials with relevant features and 
applications. 
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Table 6: Materials for tissue engineering scaffolds. 
Material  Relevant features and application 
Naturally-
derived 
Collagen-based scaffolds Soft tissue repair, Cell differentiation, 
Capillary engineering, Dermis 
engineering, Vascularized adipose 
tissue (Battista, et al., 2005; Hudon, 
et al., 2003; Pachence, 1996; Stark, et 
al., 2006; Sokolsky-Papkov et al., 
2007)  
Hyaluronic acid and 
derivatives 
Regeneration of skin, cartilage, 
Patterning of cell growth (Segura et 
al., 2005). 
Collagen-Hyaluronic acid 
gels 
Control of vascular sprouting 
(Borselli et al., 2007). 
Chitosan Chitosan microsphere-integrated 
scaffold, Cartilage engineering (Lee 
et al., 2004; Shi et al., 2006). 
Fibrin Vessel engineering, Release of 
fibroblasts (Jeon et al., 2005; Ye et 
al., 2000). 
Gelatin Trachea engineering, Bone 
engineering (Ito et al., 2003; 
Okamoto et al., 2004) 
Alginate Vascular engineering (Perets et al., 
2003). 
Synthetic PGA Musculoskeletal tissue engineering 
(Day et al., 2004; Lutolf and Hubbell, 
2005). 
PLA 
PLGA Cartilage regeneration, Fibrovascular 
engineering 
PCL Skin engineering (Ng et al., 2001) 
Polyethylene glycol (PEG) Bone formation (Lutolf et al., 2003). 
Inorganic Hydroxyapatite (HA) Bone substitute (LeGeros, 2002; Paul 
and Sharma, 2003). 
 
Polymer nanofibers have been fabricated using a number of different techniques. 
The methods of nanofiber fabrication are varied and utilize physical, chemical, thermal, 
and electrostatic fabrication techniques. The methods of polymer nanofiber fabrication 
most commonly associated with tissue engineering scaffolds in the literature are 
electrospinning, self-assembling peptide reactions, and phase separation (Ma et al., 
2005; Vasita and Katti, 2006; Venugopal et al., 2008).  
5.2.1. Electrospinning 
It is generally agreed that electrospinning has the potential to produce scaffolds 
possessing the appropriate strength, nanoscalar structure, economic appeal, and 
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biocompatibility (Lannutti et al., 2007; Pham, Sharma, and Mikos, 2006). Some of its 
advantages and disadvantages are present in Table 7: 
Table 7: Advantages and disadvantages of electrospinning process (adapted from Beachley and Wen, 
2009). 
E
le
ct
ro
sp
in
in
g
 
Advantages Disadvantages 
Easy to setup  Poor cell infiltration into the core of 
the scaffolds; 
Cost effective 2D pore or microstructure 
arrangement; 
High level of versatility allows 
control over fiber diameter, 
microstructure and arrangement 
Toxic solvents often used. 
 
Vast materials selection  
 
Electrospinning is an ideal method for producing a network of fine fibers that 
mimic the in vivo ECM (Lannutti et al., 2007; Veleva et al., 2008). The fibrous 
structures produced by the electrospinning process have a high surface area to volume 
ratio providing enhanced cell response and potentially a higher cell density per unit 
volume compared to other structures (Veleva et al., 2008). Over the past decade, many 
natural and synthetic compositions have been electrospun in targeting specific 
biomedical applications (Veleva et al., 2008; Xu et al., 2004). Many different types of 
molecules can be easily incorporated during the electrospinning fabrication process to 
produce functionalized nanofibers (Beachley and Wen, 2009). 
There are basically three components to fulfil the process: a high voltage 
supplier, a capillary tube with a pipette or needle of small diameter, and a metal 
collecting screen (Huang et al., 2003; Xie et al., 2010).  
In the electrospinning process a high voltage is used to create an electrically 
charged jet of polymer solution or melt out of the pipette (Beachley and Wen, 2009; 
Huang et al., 2003). Before reaching the collecting screen, the solution jet evaporates or 
solidifies, and is collected as an interconnected web of small fibers (Deitzel et al., 2001; 
Fong and Reneker, 2001). One electrode is placed into the spinning solution/melt and 
the other attached to the collector. In most cases, the collector is simply grounded, as 
indicated in Figure 8 (Huang et al., 2003). 
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Figure 8: Manufacturing process of electrospinnig nanofibers (Beachley and Wen, 2009). 
The electrospinning process seems to be the only method which can be further 
developed for mass production of one-by-one continuous nanofibers from various 
polymers (Huang et al., 2003).  
Many parameters can influence the transformation of polymer solutions into 
nanofibers through electrospinning (Doshi and Reneker, 1995). These parameters 
include (Beachley and Wen, 2009; Doshi and Reneker, 1995): 
a) the solution properties such as viscosity, elasticity, conductivity, and surface 
tension; 
b) hydrostatic pressure in the capillary tube, electric potential at the capillary tip, 
and the gap (distance between the tip and the collecting screen); and  
c) Solution temperature, humidity, and air velocity in the electrospinning 
chamber. 
5.3. Tissue-inducing substances 
Another important factor of tissue engineering is tissue-inducing substances, 
which include adhesion factors and growth factors. An adhesion domain discovered 
from fibronectin and other ECM proteins contains the amino-acid sequence of Arg-Gly-
Asp (RGD), which may be engineered into the scaffold biomaterials to promote 
adhesion and control cell migration speed (Palecek et al., 1997).  
 
 
  
 
 
Chapter II – Covering microchannels with electrospun 
nanofibers for cell discrimination  
 
  
 
 
  
 37 
 
1. Introduction 
Organ reconstruction and tissue regeneration are the main concern of tissue 
engineering. To accomplish this, many researchers work every day in many different 
areas, using cell culture, which has a key importance due to its high potential. The 
materials used in tissue engineering should offer total biocompatibility. They should 
have other properties like biodegradable and non-toxic, for example. The most common 
name for this cell supports are scaffolds or nanofibers in lower scale. 
Many studies have been made with cell culture and nanofibers, almost all of 
them in a two dimensional structure, but recently the technology enabled three 
dimensional studies with help of microfluidic system. It is used the chips technology, in 
this case, photolithography, to build microchannels that allows simulation of in vivo 
properties.  
Different types of devices can find a wide range of applications, including in 
pharmaceutical industry for drug studies, or for single cell study. 
In this work, a microdevice was built with the initial purpose of placing 
nanofibers on specific chambers, and further on cells to observe their migration in 
nanofibers. The present chapter describes the methodology used, as also the results 
obtained and the corresponding discussion, including suggestions to improve the 
procedures and methods used. Finally, conclusions and recommendations were included 
in this chapter. 
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2. Methodology 
This section is divided into 3 parts, one of which describes the steps and 
techniques used to draw and make the microchannels. Then, the techniques used to the 
microdevices adhere to a suitable surface were presented and finally, the process used to 
place cells inside of microchannels. 
2.1. Design 
The model was designed with AutoCad2010 software. In Figure 9, the wafer 
model and two enlarged devices are presented. 
 
Figure 9: Drawing with two different microdevice models for print in waffer. 
Both devices have 19 mm length and 14.5 mm width. Measurements of Device 
A and B are present on Table 8. 
Table 8: Measures of microdevices A and B. 
Device Components Measures [mm] 
 
Chambers 1, 2, 3 cell inlet 3 
4 inlet/outlet 4 
a, b, c nanofibers 2 
 
Channel Length 0.2 
Width  3 
Chambers 4, 5, 6 cell inlet 3 
7 inlet/outlet 4 
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2.1.1. Photolithography, Protocol for 100 µm SU-8 
Photolithography is the manufacturing process used to microfabrication of 
channels. To perform this procedure is necessary to use a clean room and as such all the 
procedures that this entails. 
Before enter in clean room, it was prepared all the material to be used: reagents 
(H2O2 and H2SO4), wafers with 4 inch and photo masks. First it was turned on the 
equipment: UV exposer and laminar flow hood. Then wafers were cleaned with piranha 
solution (50% H2O2 + 50%H2SO4) for a total of 60 ml, during 5 minutes. The wafers 
were submerged in deionized water for 1.5 minutes. This step was done twice. Wafers 
were dried with an air gun and were place in spin coater for a few seconds, to ensure 
that they were dry. Next step was to place them on the hotplate at 200ºC for 20 minutes. 
Wafers were taken out and cooled for 5 minutes and then positioned in spin coater and 
deposited 4ml (1ml per inch) of the SU – 8 100 resin (photoresist) on centre of each 
wafer with the help of a pipette. The spin coater was turned on with speed of 500rpm 
over 15 seconds and then more 30 seconds at 3000rpm. Wafers were placed on a 
hotplate levelled for soft bake. They were baked for 30 minutes at 95ºC. Then, wait to 
cool on room temperature for 10 minutes. Mask was placed on UV exposer and aligned 
such as wafers for expose the photoresist to intense light. The machine was prepared to 
five cycles of one minute each. To conclude the procedure the wafers were placed in 
revealing solution twice for 8 minutes each. The wafers were submerged in isopropanol 
and was dried. 
2.1.2. PDMS fabrication 
To make moulds of microdevices using previous wafers made by 
photolithography, PDMS was chosen. To fabricate PDMS it was necessary to clean 
wafers with ethanol and then dry them with the help of a liquid nitrogen gun. It was 
used a mixer to do the PDMS. First it was placed in the container PDMS and curing 
agent in a 10:1 ratio. The mixer (Figure 10B) was turned on and the container was 
attached, mixing the PDMS and the curing agent during 3.30 minutes at 3000rpm. 
PDMS was placed inside the Petri dish on top of the wafer and to eliminate air bubbles 
it was used the vacuum box (Figure 10C). Let it rest for one day to solidify. 
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Figure 10: Manufacturing PDMS: (A) Balance; (B) Twister; (C) Desiccator. 
2.2. Strategies to adhere PDMS on a substrate 
It was necessary to adhere the PDMS on different substrates for discoverer the 
better material to do the experiences. The oxygen plasma method and the PDMS glue 
method are explained in next points. 
2.2.1. Oxygen plasma method  
Slide glass, PDMS device and plate wells were used. The oxygen plasma 
machine was turned on and the material was placed in the metal plate with the surfaces 
that it was necessary bond turned up. It was necessary adjust the pressure of machine to 
0.75 bar, time 30 seconds and turned on. After completing the process material were 
taken out. At last, the PDMS was placed on the substrate (slide glass or plate wells) 
with careful and wait a little bit, depend of what materials we used. 
2.2.2. PDMS glue method 
PDMS was used as glue in this method. It was placed a thin layer of PDMS (not 
cured) on the substrate (plate wells or slide glass). Then it was placed the microdevice 
on the substrate with glue. Materials were placed in oven during 1h at 60ºC or 40ºC 
during 15 minutes. 
2.3. Cell culture of Adipose-derived stem cells (ADSCs) 
Green Fluorescent Protein (GFP) ADSCs were isolated from GFP-mice kindly 
provided by Dr. Prósper from Clínica Universidad de Navarra, Pamplona, Spain. 
(Mazo et al., 2008). Briefly, GFP adipose tissue cells were isolated from mice inguinal 
and interscapular adipose tissues. Inguinal fat pads were digested at 37 °C in DMEM-
F12 (Invitrogen) containing 2% bovine serum albumin (BSA) and 2 mg/ml collagenase 
(Roche, Barcelona, Spain) for 30 min. After filtration (25 μm filters), mature adipocytes 
were separated from the stromal fraction by centrifugation (600g for 10 min). The 
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pellet was re-suspended in culture medium and cells were then seeded (10,000 cells/cm
2
) 
in DMEM-F12 with 10% Fetal Calf Serum (FCS) medium and maintained in 5% CO2 
and humidified atmosphere. Six hours after plating, all non-adherent cells were removed 
by washing. Sub-confluent ADSCs were obtained after 6 days. After trypsinization, the 
cells were counted and ready to use in further cell culture experiments.  
2.4. Preparation of PCL electrospun scaffolds 
PCL of which molecular weight were 80 kDa were purchased from Sigma–
Aldrich (St Louis, MO, USA) and used without further treatment or purification. PCL 
solution with chloroform (Merck Chemical Co., Germany) was vigorously stirred with a 
magnetic stir bar for at least 24h at room temperature. Electrospinning was carried out 
at room temperature in a vertical spinning configuration, using a 1 mm inner diameter 
flat-end needle with a 10 cm working distance. The applied voltages were in the range 
from 10 to 13 kV, driven by a high-voltage power supply (Knürr-Heizinger PNC, 
Germany). The flow rates were adjusted with a programmable syringe pump (model 
210, KD Scientific Inc., USA). The collector consisted of a 10 × 15 cm metal sheet 
covered in non-stick aluminum foil. To make two different densities of scaffolds, we 
collected fibers for low fiber density in 1 min (approximately 10 m in thickness) and 
for high fiber density in 5 min ( 100 m). All electrospinning processes were carried 
out under ambient conditions. 
2.5. Scanning electron microscopy (SEM) 
The size and morphology of the electrospun fibers were investigated by a 
scanning electron microscopy (Phenom G2 Pro Desktop Scanning Electron Microscope, 
Eindhoven, The Netherlands). The diameter of the fibers and their size distribution were 
analyzed by measuring over 200 fibers in randomly recorded SEM micrographs using 
an image analyzer (Image J, developed by the National Institute of Health, USA), for 
which the samples were directly electrospun on the aluminum foils. Scaffold thickness 
with different density and surface morphology of the electrospun fibers after incubation 
for 24h in phosphate-buffered saline (PBS) for the degradation tests were also 
investigated with SEM. All samples were attached to SEM mounts using carbon film, 
and then sputtered with gold to avoid overcharging. 
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3. Results and Discussion 
The results are dividing in 3 parts. The first part has results of the 
photolithography process. Then, the second part has results obtained on the best option 
to adhere the PDMS devices on a substrate. The last part has the culture cells on 
microdevices, where it was described strategies used to place cells on devices. 
3.1. Photolithography measurements 
Microdevices in study were design with purpose to cover nanofibers scaffolds 
for cell discrimination (Figure 11). Because of this, it was necessary to make sure of its 
viability before placing nanofibers in microdevice.  
 
 
Figure 11: Microdevices (A) nanofibers in chambers a, b and c; and (B) nanofiber in channels. 
First, it was necessary to ensure that the height was correct. So, after the process 
of photolithography, the measurements were made with Tencor. Table 9 shows the 
results obtained. 
Table 9: Thickness of the cured resin 
 
 
 
Location Height 
Row 1, column 2 ~98µm 
Row 1, column 3 ~110µm 
Row 3, column 3 ~102µm  
Row 4, column 1 ~91µm 
Row 4, column 3 ~98µm 
Average 99.8 µm 
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The height that was pretended was 100 µm. The photolithography process was 
successful, with an average of 99.8 µm. While not uniform, it did not presented 
significant discrepancies. 
3.2. PCL electrospun fibers 
The Figure 12 shows PCL fibers obtained by electrospinning described 
previously in this chapter on methodology. 
 
Figure 12: SEM pictures of PCL fiber (about 1µm) produce by electrospinning from the solution with 
Chloroform/Methanol 4/1 v/v (mixture solvent). 
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3.3. Strategies to adhere PDMS on a substrate 
The strategies used show different results. In the next subchapters, the results 
and the best way chosen to adherence PDMS microdevice on a substrate will be 
presented.  
3.3.1. Oxygen plasma method  
Table 10 shows the procedure used to the adherence for culture dish and slide 
glass and the result obtained. 
Table 10: Techniques used to adherence using oxygen plasma and procedure used. 
Materials Procedure Results 
Culture dish and device Follow the protocol of machine 
and wait 18h. 
Good adhesion 
between the materials 
Slide glass and device Follow the protocol of machine 
and wait 2h. 
Good adhesion 
between the materials 
Culture dish, device and 
nanofibers 
Follow the protocol of machine 
and wait 18h. 
Detach when placed 
medium in 
 
The different materials used, culture dish and slide glass, had good results and 
proved to be a good option for the further experiences. However, slide glass was better 
because spent less time than the culture dish.  
The possible advantage of culture dish is savings of medium (next subchapter 
shows this regarding evaporation of medium during culture). 
3.3.2. PDMS glue method 
Table 11 shows the procedure used to the adherence for culture dish and slide 
glass and the result obtained. 
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Table 11: Techniques used to adherence using PDMS glue and procedure used. 
Materials Procedure Results 
Culture dish, device 
and nanofibers 
Step 1: place a thin layer of PDMS in 
plastic culture dish 
Step 2: place the nanofibers in 
PDMS layer 
Step 3: place the device in nanofibers 
Step 4: place everything in an oven 
1h at 60ºC 
The dish deform 
The channels of device 
were attaches 
It had many air bubbles 
Nanofibers degraded 
with the temperature  
Slide glass, device 
and nanofibers 
Step 1: place a thin layer of PDMS in 
a glass with a lamella  
Step 2: place the nanofibers and then 
the device 
Step 3 : place everything in oven 
during 15 minutes 40ºC 
Good adhesion 
Few air bubbles 
Channels were not 
attaches 
 
The PDMS glue method had worst results. When placed in the oven during one 
hour at 60ºC the dish culture deform and melt; device channels were attached to the dish 
culture and many air bubbles were observed. 
The strategy that used the slide glass showed better results because the device 
channels were not attached and only a few air bubbles were visualized. 
The best strategy when nanofibers are not used was oxygen plasma with slide 
glass substrate. But this strategy is not so good when cells were placed on the channels, 
because of the medium evaporation. On the case of culture dish, it was possible to place 
medium in less quantity. 
To place nanofibers on device the strategy with glue PDMS method was better, 
despite some problems that occurred. 
3.4. Cell culture in microdevice 
3.4.1. Microdevice A 
Microdevice A was used in first place. After the adhesion step it ensured that 
channels and chambers were clear and detached from slide glass. For this reason it was 
passed water into the microdevice it was found that all of chambers, channels and 
wholes were clear. 
Second, it was chosen the flow rate. It was chosen a flow rate to place cells in 
chamber at 0.1 ml/h and filled the microdevice with medium 0.1 ml/min. Due to the 
small size of the device, flow rate had to be low to control the input of cells. 
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Third, it was necessary verify if cells migrate through channel, from chamber 2 
to chamber b. 
In this step several tests were made. 
 
First test: Placed cells only in one chamber 
Important data used in microdevice A: 
 Flow rate for medium: 0.1 ml/min; 
 Flow rate for cells: 0.1 ml/h; 
 Filled time for cells: ~2 minutes. 
It were followed these steps: 
1. Was filled with cells in chamber 2; 
2. Was filled with medium in chamber 4; 
3. Were taken results photographically with epi-fluorescence microscope. 
I was observed cells on the day that it was filled the device and the day after. 
The Figure 13 shows the result for day one. 
 
Figure 13: Cells filled - Chamber location: Chamber 2, b. 
It was found that all chambers had many air bubbles, which is not good for the 
cells survive neither their migration. Using a pump to put booth cells as the medium 
proved to be very useful. 
The microdevice A was placed in the incubator for 24 hours to preserve good 
health of cells and the result of that was the evaporation of medium. One reason for this 
is the holes, which were made to place the medium and cells, and the temperature of the 
incubator. One possible solution would be covering channels with a slide glass. 
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Second test: Placed cells only in one chamber 
Important data used in the microdevice A: 
 Flow rate for medium: 0.1 ml/min; 
 Flow rate for cells: 0.1 ml/h; 
 Filled time for cells: ~5 min. 
It was followed these steps in this experiment: 
1. Was filled with medium in chamber 4; 
2. After all the device was filled with medium, cells were placed in the 
chamber 1 during 5 minutes, because chamber 2 was blocked; 
3. Were taken results photographically with epi-fluorescence microscope. 
I was observed cells on the day that it was filled the device and in the day after. 
The Figure 14 shows the result to day one. 
 
Figure 14: Cells filled - Chamber location: Chamber 1, b. 
The results were taken 4h after filling the microdevice with cells. It was 
observed that cells are in almost all of the device, with the exception of the middle 
chambers. So 5 minutes to fill the chamber with cells was too much time. 
In the next day, 24h after, almost all cells died, Figure 15. 
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Figure 15: 24h after filled chamber with cells. 
In Figure 15 it was possible see cells in chambers 1, 3, 4 and the medium did not 
evaporate like last time. Cover-glass the device was able to prevent the medium 
evaporation. It was found that some cells were attached in different areas, as shown in 
Figure 16. 
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Figure 16: Images from cells found in microdevice A, in second test. 
 
Third test: Placed cell only in one chamber 
Important data used in the device 3: 
 Flow rate for medium: 0.1 ml/min; 
 Flow rate for cells: 0.1 ml/h; 
 Filled time for cells: 1 min. 
It was followed these steps in this experiment: 
1. Was filled with medium in chamber 4; 
2. After all the device was filled with medium, placed cells in the chamber 2 
during 1 minutes; 
3. Were taken results photographically with epi-fluorescence microscope. 
It was observed cells on the day we filled the device and in the day after. The 
Figure 17 shows the result. 
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Figure 17: Cells in microdevice A, 4h after filled. 
In this test we only had cells in centre of device, chamber 2, b, 4. 
 
Figure 18: cells on microdevice A, 24h after filled. 
This procedure was more successful with regard to placement of cells, however, 
it was only necessary to place cells in the chamber 2, and that was not obtained. 
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4. Conclusions and Recommendations 
The oxygen plasma was the technique to adhere PDMS to a substrate that gave 
good results. But, when nanofibers were placed on the device this choice was not so 
good, because the nanofibers are very thin and flexible and it was difficult to work with 
them in a short period of time. The oxygen plasma only have half an hour to bounding 
the materials and it is a short period to place nanofibers in proper local and bonding the 
material. 
Seeding cells on devices was another challenge, and was verifying that the pump 
with a flow rate and time controlled was a viable choice. 
Beside all this issues, the other geometry was not tested. It was suggested 
another device design. The new geometry design has two layers that would be a good 
solution to insert the nanofibers and cells without initial problems obtained on first 
geometry, respectively when nanofibers were placed. Controlling the cell entrance is 
very important, and this geometry could help us, because it was possible to place cells 
with different inlet. Furthermore, in this new geometry, the height of channels and 
chambers was different.  
 
  
 
 
  
 
 
Chapter III – Effect of tumour cells on deformability of 
erythrocytes 
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1. Introduction 
Nowadays, cancer is the most popular and mortal disease and therefore, the 
investigation for understanding its proliferation and how it is possible to control and 
treat the disease are very important.  
―Membrane of Red Blood Cell will be modified in contact with tumour cells?‖, 
this is the question that emerges. We know that erythrocytes of diabetic people have a 
rigid membrane compared with normal people. So, is it possible that the same thing 
occurs when people have tumours? 
In this chapter different biomedical devices were tested in order to achieve the 
proposed objectives and overlap some difficulties. The microdevices described in the 
previous chapter were firstly applied. The first barrier was the adhesion of the PDMS 
device with any substrate. The second obstacle was the good adherence of cells on 
microdevice. Therefore, it was decided to use tumour cells to evaluate their influence in 
the deformability of erythrocytes. To be able to see deformation, a specific device 
presented on Figure 19 was used. 
 
Figure 19: Deformation microchannel with 20 µm of width. 
 
The present chapter describes the methodology used, and also the results 
obtained and the corresponding discussion, including suggestions to improve the 
procedures and methods used. Finally, conclusions and recommendations were included 
in this chapter. 
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2. Methodology 
In this section the procedures used to evaluate deformability of RBCs in the 
presence of tumour cells are described. 
2.1. PDMS glue method 
PDMS was prepared with a proportion of 20:1. A glass slide was placed on spin 
coater vacuum. A portion of PDMS previously prepared was placed on slide glass. The 
spin coater was turned on with following program: 3000rpm, during one minute and 
4000rpm, during one more minute. After finish program the slide glass was taken out 
and placed in the oven during 10 minutes at 80ºC. After the specific time the PDMS 
device was placed on slide glass and placed again in the oven during 24h. 
2.2. Surface modification and adhesion with piranha and KOH solution 
To prepare 50 ml of 1M KOH solution, 3.2060 g of KOH were dissolved in 50 
ml of water. 
To prepare 50 ml of piranha solution (2:3), 30 ml of H2SO4 was placed in a 
recipient and then slowly and very careful H2O2 was added to the same recipient. 
Microdevices were placed in piranha solution during 15 minutes and mixed from time 
to time. After 15 minutes, microdevices were removed and rinsed with deionized water. 
Then, microdevices were placed in KOH solution for the same period and, after this, 
rinsed with DI water. Microdevices were placed in oven at 80ºC during 4h. 
2.3. Preparation of erythrocytes 
2.3.1. Bovine blood 
The bovine blood was collected, divided in two falcon tubes and centrifuged 20 
minutes at 1200rpm. After this, the plasma (supernatant) was removed and mixed with 
HBSS (twice of volume). It was centrifuged again for 5 minutes at 1200 rpm and 
plasma was removed again. The procedure was repeated 3 more times. In the end, the 
plasma was removed, mixed with HBSS and centrifuged for 10 minutes at 1200rpm. 
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2.3.2. Human blood 
Human blood was collected, divided in two falcon tubes and centrifuged 10 
minutes at 1000 rpm. After this, the plasma was removed, mixed withed HBSS and 
centrifuged again 10 minutes at 1000rpm. The plasma was removed again and 
resuspended in HBSS at a known concentration (2%). 
2.4. Culture medium preparation 
To prepare 100 ml of medium, RPMI 1640 (87 ml) was supplemented with fetal 
bovine serum (10% FBS, 10 ml), 100 U/ml streptomycin/penicillin antibiotic (1 ml), 2 
mM glutamine (1 ml), and essential amino acids (1 ml) and further heated at 37ºC.  
2.5. Cell culture  
Two human tumour cell lines were used: NCI-H460 (non-small cell lung cancer) 
and HCT-15 (colon carcinoma). Cells were routinely maintained as adherent cell 
cultures in culture medium previously described, at 37ºC, in a humidified air incubator 
containing 5% CO2. Each cell line was plated at an appropriate density (2 × 10
5
 
cells/well for NCI-H460 and HCT-15) in 6-well plates and mixed with 1 ml of 
erythrocytes (2% Htc). One sample erythrocytes was taken after 24h of incubation and 
another one after 48h. 
2.5.1. Assessment of cells growth inhibition using Sulforhodamine B 
colorimetric assay  
After the culture period (24 or 48h), the adherent cells were fixed by adding cold 
10% trichloroacetic acid (TCA, 100 µl) and incubated for 60 minutes at 4 ºC. Plates 
were then washed with deionized water and dried; sulforhodamine B solution (0.1% in 
1% acetic acid, 100 µl) was then added to each plate well and incubated for 30 min at 
room temperature. Unbound SRB was removed by washing with 1% acetic acid. Plates 
were air dried, the bound SRB was solubilised with 10 mM Tris (200 µl) and the 
absorbance was measured at 540 nm in a microplate reader. 
2.6. Deformability and recuperation tests for large channel 
To evaluate the deformability of erythrocytes that were in contact with tumour 
cell lines, a channel was used (Figure 20).  
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Figure 20: Geometry used to test deformability of erythrocytes. 
 
For this study, 6 sections were defined on the channel (Figure 21). 
 
Figure 21: Sections defined on the channel used in the present study. 
 
The most important sections were the first ones, where the deformation occurs. 
Section 5 and 6 were only to see recuperation of erythrocytes. 
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3. Results and Discussion 
The devices made on CEIT and described in chapter II were firstly used to 
perform cell culture.  Nevertheless, some problems occurred regarding the adhesion of 
PDMS to glass plate (the technique used to the adherence was the PDMS glue method, 
described on the previous section). Problems to place cells on device were observed– 
the PDMS is hydrophobic, and because of that cells do not attach. It was necessary to 
find another way to make adhesion between PDMS and glass, in order to make it 
hydrophilic. Maji et al. (2012), performed a study of hydrophobicity and stability of 
chemically modified PDMS surface using piranha solution and KOH solution. They 
tested three different ways to make PDMS hydrophilic and measure the contact angle, 
using FTIR to confirm results. 
To change the surface of PDMS, their procedure was followed (described on the 
previous section). Besides changing the surface of the PDMS, it may also be used to 
create adhesion. Therefore, it was tried adhesion between PDMS and glass, and PDMS 
and petri dish culture. 
The cells were prepared and placed on the changed devices. After one day, the 
cells were dead. So, the surface modification was temporary and takes only a few hours. 
Even if the cells were able to adhere, after a few hours they were repelled by the device 
and died. 
In this way, different devices were used to study deformability of erythrocytes, 
after contact with human tumour cells. 
3.1. Deformability of erythrocytes 
The next experiments were performed using bovine and human erythrocytes. 
3.1.1. Experiment 1 - Bovine erythrocytes 
The device had 14 µm of height. 
To obtain images and videos, an Olympus camera attached to an inverted optical 
microscope. It was very difficult to observe bovine erythrocytes. Figure 22 shows an 
example of quality of images that was possible to obtain. 
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Figure 22: Erythrocyte images captured at 2000fps, 40x +1.6 x zoom with a flow rate of 100nl/min. 
 
The blue circle indicates the location of erythrocytes, being evident their bad 
definition. With 2000fps, the light was lost being only possible to see the erythrocyte 
when they had already passed the channel. To see deformation it is required to see 
erythrocytes in the channel. 
The control of the flow rate on the channel was another important difficulty. The 
pump was defined for the minimum flow rate, 100 nl/min, but probably it was too much 
because the erythrocytes crossed very fast. Nevertheless, it is still visible that some cells 
do not deform. 
Because of all these issues the human erythrocytes were chosen as a sample fluid. 
3.1.2. Experiment 2 – Human erythrocytes  
For this experiment, the video camera was changed. All videos were taken with 
canon film camera, fixed on an inverted optical microscope. The important options 
made for the videos were the frames per second, 7500, the recording window, 1024x256, 
the objective, 20x with precision 0.75 and the velocity of the flow, 500 nl/min. 
The videos were treated on ImageJ software following the steps presented below. 
First the videos were opened in ImageJ software and converted to sequences of 
JPEG images (stack). Then, the image stack was opened the sequentially and 
incremented by 4 at the same time as shown in Figure 23. 
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Figure 23: ImageJ software image sequence operation. 
The next step was calibrating the images. The minimum distance of the channel 
at the exit of contraction part, known as 20µm, was used as a reference to calibrate and 
2.100 pixels/µm was set as a scale (see Figure 24). 
 
Figure 24: Image calibration in ImageJ. 
After calibration, it was necessary to rotate the images slightly, because they 
were not horizontally aligned. The angle of rotation could be different according to the 
images. Then, a background image was created applying median operation to the stack, 
by using ImageJ function Z-project. The background image contains only static objects 
such as microchannels walls and noises as shown in Figure 25. 
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Figure 25: Background image. 
This image was used to subtract from the original image with the ImageJ 
function Image Calculator (see Figure 26).  
 
Figure 26: Step of Image Calculator. 
The image obtained from the procedure above is presented in Figure 27. In this 
image only flowing RBCs are visible. 
 
Figure 27: Subtracted image. 
The brightness and contrast were adjusted to ensure the good definition of 
erythrocytes and then Otsu threshold method was applied (see Figure 28). 
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Figure 28: Threshold options step. 
After this operation, the images were transformed in black and white (binary 
images). Finally, RBCs were measured by ImageJ function Analyze Particles (see 
Figure 29). 
 
Figure 29: Options to analyze particles. 
The program runs and flowing RBCs were measured frame by frame, and the 
results were recorded as a table as shown in Figure 30. 
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Figure 30: Results table and image results. 
The table of results contains many measurements elements (columns) and for the 
current studies several elements were used, that are presented in Figure 31 in the orange 
rectangles. 
 
Figure 31: Results table and the elements used for analyses. 
The first column is the sequential ID number assigned to the erythrocytes which 
were measured in each frame. The second one is the area of particle, and then X and Y 
presents the center position of particle, Major and Minor are the major and minor axis 
lengths of an ellipse that best fits the particle. 
In order to use only necessary data, the results were treated by the following 
stages. 
(1)  The minimum area was set to be 10 µm2 to eliminate errors from the results 
(2)  X corresponds to the length of channel and it was divided into 6 sections for 
analyses (see Figure 21), so X is limited to these sections. 
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(3)  Y is the width of the channel and it is limited, too. Sections 1-4 have 14 µm 
in middle of channel. The other sections do not have limit. 
(4)  DI (deformation index) is calculated by following the equation in Figure 32. 
X and Y correspond to Major and Minor respectively. 
 
 
Figure 32: Definition of deformation index (DI). 
For this experiment, a work plan was made and its resume is in Table 12. 
Table 12: Resume table of work plan. 
 0h 24h 48h 
Human 
Erythrocytes  
Case 1 Case 2 Case 3 
Human 
Erythrocytes + 
HCT15* 
- Case 4 Case 5 
Human 
erythrocytes + 
NCI-H460* 
- Case 6 Case 7 
*  tumour cell lines 
 
For each case, several videos were recorded to observe erythrocytes deformation 
for 2% haematocrit (Hct): 
Case 1: Erythrocytes with HBSS, ambient temperature control 
Case 2: Erythrocytes with medium, 24h, 37ºC, 5% CO2 
Case 3: Erythrocytes with medium, 48h, 37ºC, 5% CO2 
Case 4: Erythrocytes in contact with HCT - 15, 37ºC, 5% CO2 
Case 5: Erythrocytes in contact with HCT - 15, 48h, 37ºC, 5% CO2 
Case 6: Erythrocytes in contact with NCI-H460, 24h, 37ºC, 5% CO2 
Case 7: Erythrocytes in contact with NCI-H460, 48h, 37ºC, 5% CO2 
Videos of each case were compared to know which one better represent the 
expected behaviour of erythrocytes in the channel. 
The comparison of videos for case 1 was represented in Figure 33. 
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Figure 33: Comparison of DI for all videos in Case 1 in each section. 
 
It was expected more deformation in section 3 than in the other sections as it is 
right before the exit part of the contraction part in the channel. The videos that show the 
ideal behaviour of erythrocytes in the channels are videos 1, 2 and 4. Video 3 have a 
missing value that corresponds to section 3. This was due to the number of RBCs being 
greatly reduced in some samples and also the method used to make the measurements. 
In our case it was the automatic method described early in this chapter. 
In the first 3 sections in all of videos it is possible to see the expected behaviour 
of RBCs, an increase of DI. In section 4, 5 and 6 it was expected a decrease of DI and 
this is observed too, in all of videos. 
Figure 34 shows the comparison between all videos of case 2. 
0.00
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
Video1 Video2 Video3 Video4
D
I 
Case 1 
Section1
Section2
Section3
Section4
Section5
Section6
 67 
 
 
Figure 34: Comparison of DI for all videos in Case 2 in each section. 
Video 1 and 2 does not have the section 3. Among all the videos it was 
impossible to choose one because section 3 (the most important section to see maximum 
deformation) is missing in all the cases. However, there can be seen a tendency that DI 
increases from section 1 to 2, and decreases dramatically at section 4.  
The missing values are not present because of the explained reasons in the case 1 
(very few RBCs and the used method to measure DI). 
Figure 35 gives the comparison between videos of case 3. 
 
Figure 35: Comparison of DI for all videos in Case 3 in each section. 
In this case it was observed the same problem as the previous cases. In the 3 
videos the section 3 was missing. But the expected behaviour to the section 1, 2 and 3 
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was observed. In the video 1 the section 6 does not exist, too. Sections 4, 5 and 6 shows 
slightly different tendency among the 3 videos. However, this could be due to errors 
caused by the image quality. 
Figure 36 shows the comparison between videos of case 4. 
 
Figure 36: Comparison of DI for all videos in Case 4 in each section. 
 
In this case 2 videos were obtained. Bode videos correspond well with the DI 
tendency observed in case 1, 2 and 3 but DI value is relatively lower. For instance, the 
maximum value in case 1 is about 0.55 whereas about 0.28 in case 4, and both values 
are from the same section 3. 
Figure 37 shows the comparison between videos of case 5. 
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Figure 37: Comparison of DI for all videos in Case 5 in each section. 
 
Once more, a lot of values are missing. For example, video 1 does not have 
section 5 and 6 and video 2 has only section 2, 3 and 4. Nevertheless, the graph shows 
similarity with case 5 and the maximum DI value was found in section 3. 
Figure 38 gives the comparison between videos of case 6. 
 
Figure 38: Comparison of the DI for all videos in Case 6 in each section. 
 
In this case, only one video was obtained and was missing sections 2 and 3. 
Although it might not be relevant to observe, the graph shows a tendency that in 
sections 4 to 6 DI values are smaller than in section 1. 
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Figure 39 is the comparison between videos of case 7. 
 
Figure 39: Comparison of DI for all videos in Case 7 in each section. 
 
In this case, a lot of values are missing. The DI was not correspondent to the 
ideal behaviour seen in the other cases. 
Figure 40 represents the average of all videos that were obtained for the cases 1, 
4 and 5. 
 
Figure 40: Comparison of average of DI to the cases 1, 4 and 5 for all videos.  
 
As already have been shown, the results of image analysis include several lack 
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method. Therefore, Case 1, 4 and 5 were used for comparison but Sections 5 and 6 were 
not compared due to lack of data. 
By observing all the cases in the figure above, it is possible to say that DI 
increases from Section 1 to 3 and then at Section 4 DI dramatically decreases. The DI of 
Case 1 in Section 1, 2 and 3 are significantly higher than that of Case 4 and 5. The Case 
1 is the erythrocytes that do not have contact with any tumour cell line whereas Case 4 
and 5 are in contact with HCT15 for 24 hours and 48 hours respectively. Hence, it is 
possible to say that the healthy RBCs contacted with tumour cells for at least 24 hours 
get influence for their deformability, that is the increase of rigidity. In terms of DI 
comparison between Case 4 and 5, no significant difference is observed for all the 
sections. This could mean that the duration of time in contact with HCT - 15 for more 
than 24 hours is not an important influential factor for deformability of RBCs. 
The current study has shown that for healthy erythrocytes a contact with tumour 
cells provides an influence, decreasing their deformability. However, to consolidate this 
result, further studies need to be conducted including high Hct environment and solid 
measurement methodologies.  
3.2. Comparison between NCI-H460 and HCT15 cell lines 
To evaluate if erythrocytes influence the growth of the cells, their growth 
inhibition was accessed by Sulforhodamine B colorimetric assay previously described. 
It was observed a decrease of 17.98% in the growth of HCT - 15 cells that were in 
contact with erythrocytes (Figure 41). 
 
Figure 41: A - HCT15 cell line; B – HCT15 cell line with erythrocytes. 
It was observed a decrease of 7.60% in the growth of NCI-H460 cells that were 
in contact with erythrocytes (Figure 42). 
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Figure 42: A –NCI-h460 cell line; B – NCI-H460 cell line with erythrocytes. 
Overall, NCI-H460 cells proved to be less susceptible to erythrocytes presence 
than HCT15 cells. 
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4. Conclusions and Recommendations 
In this study, erythrocytes deformability with a contact of tumor cells was 
examined using a hyperbolic microchannel. Despite several lack of data, there can be 
seen a tendency that the contact of tumor cells decrease deformation of RBCs. This was 
notably observed at the contraction part of the microchannel. The duration of time that 
tumor cells contact with healthy RBCs more than 24 hours did not show any significant 
differences. In order to confirm these results further studies are necessary with various 
conditions such as higher Hct.  
Growth of tumor cells, NCI-H460 and HCT15, in contact with healthy RBCs 
was also examined. In both cases, their growth was suppressed but the NCI-H460 
samples showed less susceptible presence than the HCT15 samples. Detailed 
investigation will be further needed including different concentration of tumor cells as 
well as RBCs for better understanding the reasons for this difference in growth of the 
cell lines.  
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